E-LIB Suche - Ergebnisse für: de Jonge, A. Vera

1

Response to DA-EPOCH-R is associated with activation of 'fi..:

De Jonge, A. Vera ; Bruins, Wassilis S.C. ; Duetz, Carolien...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC..:

de Jonge, A. Vera ; Duetz, Carolien ; Bruins, Wassilis S. C....
Blood Advances. 8 (2024) 5 - p. 1094-1104 , 2024

Link: https://doi.org/10.1182/..

3

A non-randomized risk-adjusted comparison of lenalidomide +..:

de Jonge, A. Vera ; van Werkhoven, Erik ; Dinmohamed, Avinash G....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

S187: IMMUNOLOGICAL AGING HAS A NEGATIVE IMPACT ON CLINICAL..:

Bruins, Wassilis ; Duetz, Carolien ; Groen, Kaz...
HemaSphere. 7 (2023) S3 - p. e28577c3 , 2023

Link: https://doi.org/10.1097/..

5

P-380 Immunological aging is associated with worse clinical..:

Bruins, Wassilis ; Duetz, Carolien ; Groen, Kaz...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S249-S250 , 2023

Link: https://doi.org/10.1016/..

6

Preclinical activity and determinants of response of the GP..:

Verkleij, Christie P. M. ; Broekmans, Marloes E. C. ; van Duin, Mark...
Blood Advances. 5 (2021) 8 - p. 2196-2215 , 2021

Link: https://doi.org/10.1182/..

7

Epcoritamab induces potent anti-tumor activity against mali..:

van der Horst, Hilma J. ; de Jonge, A. Vera ; Hiemstra, Ida H....
Blood Cancer Journal. 11 (2021) 2 - p. , 2021

Link: https://doi.org/10.1038/..

8

Impact of MYC on Anti-Tumor Immune Responses in Aggressive ..:

de Jonge, A. Vera ; Mutis, Tuna ; Roemer, Margaretha G. M...
Cancers. 12 (2020) 10 - p. 3052 , 2020

Link: https://doi.org/10.3390/..

9

S187: IMMUNOLOGICAL AGING HAS A NEGATIVE IMPACT ON CLINICAL..:

Bruins, Wassilis ; Duetz, Carolien ; Groen, Kaz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428238/. , 2023

Link: http://www.ncbi.nlm.nih...

10

A non-randomized risk-adjusted comparison of lenalidomide +..:

de Jonge, A. Vera ; van Werkhoven, Erik ; Dinmohamed, Avinash G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203347/. , 2023

Link: http://www.ncbi.nlm.nih...

11

A non-randomized risk-adjusted comparison of lenalidomide +..:

de Jonge, A. Vera ; van Werkhoven, Erik ; Dinmohamed, Avinash G...
https://research.rug.nl/en/publications/1ff5cf35-cc4e-4b78-aa66-f15fc8f3a318. , 2023

Link: https://hdl.handle.net/1..

12

S187: IMMUNOLOGICAL AGING HAS A NEGATIVE IMPACT ON CLINICAL..:

Wassilis Bruins ; Carolien Duetz ; Kaz Groen...
http://journals.lww.com/10.1097/01.HS9.0000967660.28577.c3. , 2023

Link: https://doi.org/10.1097/..

13

A non-randomized risk-adjusted comparison of lenalidomide +..:

A. Vera de Jonge ; Erik van Werkhoven ; Avinash G. Dinmohamed...
https://doi.org/10.1038/s41408-023-00854-2. , 2023

Link: https://doi.org/10.1038/..

14

Preclinical activity and determinants of response of the GP..:

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
Verkleij , C P M , Broekmans , M E C , van Duin , M , Frerichs , K A , Kuiper , R , de Jonge , A V , Kaiser , M , Morgan , G , Axel , A , Boominathan , R , Sendecki , J , Wong , A , Verona , R I , Sonneveld , P , Zweegman , S , Adams , H C , Mutis , T & van de Donk , N W C J 2021 , ' Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma ' , Blood , vol. 5 , no. 8 , pp. 2196-2215 . https://doi.org/10.1182/BLOODADVANCES.2020003805. , 2021

Link: https://research.vumc.nl..

15

Preclinical activity and determinants of response of the GP..:

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095149/. , 2021

Link: http://www.ncbi.nlm.nih...